Business / Finance

RSS

DaVita acquires Tulips Dialysis Centre; opens two new joint venture centers in Malaysia

DaVita, a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced the acquisition of Tulips Dialysis Centre and has opened two new joint venture centers in Malaysia.

3 Dec 2012

HCA Holdings proposes to offer $1.0 billion senior notes

HCA Holdings, Inc. today announced that it proposes to offer, subject to market and other considerations, $1.0 billion aggregate principal amount of senior notes. Actual terms of the notes, including interest rate and principal amount, will depend on market conditions at the time of pricing.

3 Dec 2012

BVM Capital makes seed round investment in Fitness Interactive Experience

BVM Capital today announced that it has made a seed round investment in health and fitness gaming innovator Fitness Interactive Experience (FIX). FIX is dedicated to helping people achieve enhanced levels of fitness and health by making fitness fun, accessible and socially connected through harnessing the power of massively multiplayer on-line games. FIX is developing an interactive social media platform designed to make the pursuit of fitness an engaging and enjoyable game.

3 Dec 2012

Chromadex completes acquisition of Spherix Consulting

ChromaDex Corporation ("ChromaDex"), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure®, announced today the completion of the acquisition of Spherix Consulting, Inc., a subsidiary of Spherix, Inc.

3 Dec 2012

Pfizer sells Nutrition business to Nestlé for $11.85 billion

Pfizer Inc. announced today that it has completed the sale of its Nutrition business to Nestlé for $11.85 billion in cash, following the conclusion of the required regulatory process in most markets. In certain countries where completion will be delayed due to ongoing regulatory review, Pfizer will continue to operate the business on an interim basis.

30 Nov 2012

CACI completes transaction to acquire Emergint Technologies

CACI International Inc. announced today that it has completed its transaction to acquire Emergint Technologies, Inc., a premier provider of emerging technology solutions focused on the data-driven needs of national health organizations. This acquisition builds on CACI's healthcare IT capability and expands its presence in the growing healthcare IT market.

30 Nov 2012

HIV travel bans violate human rights, hurt business

Writing in the Huffington Post's "Impact" blog, Chip Bergh, president and CEO of Levi Strauss & Co., and Kenneth Cole, CEO of Kenneth Cole Productions and chair of the Board of amfAR, The Foundation for AIDS Research, discuss why some CEOs oppose HIV travel bans.

30 Nov 2012

EHS reports addition of 78,000 new members to Central Valley operations

EHS Medical Group reported today the addition of 78,000 new members to their Central Valley operations. The growth makes Central Valley the company's single largest region by membership outside of Los Angeles County.

30 Nov 2012

Pivotal Therapeutics reports loss of $811,164 for third quarter 2012

Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on cardiovascular disease and overall health today announced its financial results and operational highlights for the quarter ended September 30, 2012. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated.

30 Nov 2012

ArmaGen closes $17M Series A financing

ArmaGen Technologies, Inc. today announced the closing of a $17 million Series A financing to support the development of brain-penetrating recombinant protein therapeutics.

29 Nov 2012

Pall first quarter 2013 sales decrease 3.6% to $627.6 million

Pall Corporation today reported financial results for the first quarter of fiscal year 2013 which ended on October 31, 2012.

From Pall Corporation 29 Nov 2012

Rexahn intends to offer shares of common stock and warrants

Rexahn Pharmaceuticals, Inc. today announced that it intends to offer shares of its common stock and warrants to purchase common stock in an underwritten public offering.

29 Nov 2012

Ginger.io announces $6.5M Series A funding

Ginger.io, the behavioral health analytics startup, today announced a $6.5 million Series A funding round led by Khosla Ventures.

29 Nov 2012

Pfizer completes acquisition of NextWave Pharmaceuticals

Pfizer Inc. today announced that it has completed its acquisition of NextWave Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focused on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD).

29 Nov 2012

Kewaunee Scientific second quarter sales increase 20% to $31,185,000

Kewaunee Scientific Corporation today reported sales and earnings for its second quarter ended October 31, 2012.

28 Nov 2012

Merck increases quarterly dividend to $0.43 per share of common stock

Merck, known as MSD outside the United States and Canada, today announced that the Board of Directors has increased the company's quarterly dividend to $0.43 per outstanding share of the company's common stock, up $0.01 from $0.42 per outstanding share paid last quarter.

28 Nov 2012

Sonomax third quarter net revenue increases to $267,946

Sonomax Technologies Inc. today disclosed its results for the three-month and nine-month periods ended September 30, 2012.

28 Nov 2012

Big pharma and federal government predicted to play diminishing role in research funding

In a commentary to be published in the Dec. 12 issue of The Journal of the American Medical Association, two Johns Hopkins faculty members predict an ever-diminishing role for government and drug company funding of basic biomedical research and suggest scientists look to “innovative” kinds of private investment for future resources.

27 Nov 2012